[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE202100026A - 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks - Google Patents

3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Info

Publication number
EE202100026A
EE202100026A EEP202100026A EEP202100026A EE202100026A EE 202100026 A EE202100026 A EE 202100026A EE P202100026 A EEP202100026 A EE P202100026A EE P202100026 A EEP202100026 A EE P202100026A EE 202100026 A EE202100026 A EE 202100026A
Authority
EE
Estonia
Prior art keywords
composition
hydroxycyclopentanone
moiety
compound
stabilization
Prior art date
Application number
EEP202100026A
Other languages
English (en)
Inventor
Ivar JÄRVING
Original Assignee
Aktsiaselts Kevelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktsiaselts Kevelt filed Critical Aktsiaselts Kevelt
Priority to EEP202100026A priority Critical patent/EE05864B1/et
Priority to PCT/IB2022/062615 priority patent/WO2023119188A1/en
Publication of EE202100026A publication Critical patent/EE202100026A/et
Publication of EE05864B1 publication Critical patent/EE05864B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Leiutis käsitleb kompositsiooni, mis sisaldab 3-hüdroksütsüklopentanoonitsüklit sisaldavat ühendit, alkoholi või estrit või nende segu sisaldavat lahustit ning soola, mis on võimeline lahustis dissotsieeruma, või seda moodustavaid ioone. Lisaks käsitleb leiutis sellist kompositsiooni sisaldavat komplekti, meetodit kompositsiooni valmistamiseks ja meetodit 3-hüdroksütsüklopentanoonitsüklit sisaldava ühendi stabiliseerimiseks lahustis, kasutades soola.
EEP202100026A 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks EE05864B1 (et)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks
PCT/IB2022/062615 WO2023119188A1 (en) 2021-12-22 2022-12-21 Composition of compound comprising 3-hydroxycyclopentanone moiety and method of its stabilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Publications (2)

Publication Number Publication Date
EE202100026A true EE202100026A (et) 2023-08-15
EE05864B1 EE05864B1 (et) 2024-02-15

Family

ID=86901468

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP202100026A EE05864B1 (et) 2021-12-22 2021-12-22 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks

Country Status (2)

Country Link
EE (1) EE05864B1 (et)
WO (1) WO2023119188A1 (et)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
WO2015113094A1 (de) * 2014-01-30 2015-08-06 Gebro Holding Gmbh Stabile alkoholische lösung von alprostadil
WO2017015690A1 (de) * 2015-07-27 2017-02-02 Gebro Holding Gmbh Konzentrat enthaltend alprostadil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins
US4070242A (en) * 1977-03-23 1978-01-24 Miles Laboratories, Inc. Method for the preparation of prostaglandin synthetase
US20050020646A1 (en) * 2003-06-25 2005-01-27 Pfizer Inc. Treatment of BPH
AT517555A1 (de) * 2015-07-27 2017-02-15 Gebro Holding Gmbh Konzentrat enthaltend Alprostadil
RU2695068C1 (ru) * 2018-06-26 2019-07-19 Общество с ограниченной ответственностью "Гурус БиоФарм" Средство для лечения хронических облитерирующих заболеваний периферических сосудов на основе простагландина
CN110193084A (zh) * 2019-07-02 2019-09-03 付纪军 一种含聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物的药物制剂及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
US4301175A (en) * 1980-12-29 1981-11-17 The Upjohn Company E-Type prostaglandin compositions
WO2015113094A1 (de) * 2014-01-30 2015-08-06 Gebro Holding Gmbh Stabile alkoholische lösung von alprostadil
WO2017015690A1 (de) * 2015-07-27 2017-02-02 Gebro Holding Gmbh Konzentrat enthaltend alprostadil

Also Published As

Publication number Publication date
WO2023119188A1 (en) 2023-06-29
EE05864B1 (et) 2024-02-15

Similar Documents

Publication Publication Date Title
CR20220059A (es) Mezclas que comprenden plaguicidas de indazol
AU2020317609A8 (en) Novel heteroaryl-triazole compounds as pesticides
MX2021002762A (es) Compuestos de isoxazolina para controlar plagas de invertebrados.
NO20083590L (no) Biocidblandinger inneholdende pyrition- og pyrrolderivativer
PE20211461A1 (es) Compuestos de heteroarilo sustituidos con alquilamida de piridinsulfona
MD20230027A2 (ro) Amestecuri de pesticide cu conţinut de indazoli
EP4339264A3 (en) Method and use
BR112018068420A2 (pt) método e composição inibidora de hidrato
CL2020003015A1 (es) Conversión a escala preparativa de goniautoxinas en neosaxitoxina
EE202100026A (et) 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks
MX2021005710A (es) Compuestos de meta-diamida para controlar plagas de invertebrados.
MX2020008428A (es) Compuestos de naftaleno isoxazolina para controlar plagas de invertebrados.
CR20220139A (es) Inhibidor de diacilglicerol aciltransferasa 2
US20160312046A1 (en) Method for producing a coating agent
CR20240021A (es) Compuestos de azol para el control de plagas de invertebrados referencia cruzada a solicitudes relacionadas
NZ593327A (en) Compositions for the treatment of timber and other wood substrates
EP2415461A8 (en) Stabilization of interleukin 6 in serum based solutions
MX2018002777A (es) Mezcla de iniciador, composicion, su uso, proceso de preparacion de polimero de poliol y polimero de poliol obtenido por el proceso.
CN104559482A (zh) 一种环保保温内墙漆
WO2016033166A4 (en) N-propyl bromide solvent systems
MX2023011613A (es) Mezcla estabilizadora.
MX2024002431A (es) Estabilizacion mejorada de ficocianinas en composiciones acidas.
MX2024000839A (es) Una mezcla de aditivos para la estabilizacion de material organico.
MD3642175T2 (ro) Compoziție pentru pulbere de propulsie cu o singură bază pentru muniție și muniție prevăzută cu asemenea compoziție
WO2021014255A3 (en) Azeotropic solvent formulation of hydrofluoroether and organic carbonates